Previous 10 | Next 10 |
home / stock / avcrf / avcrf news
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced its plans to offer a live discussion on the company’s current activities and forward outlook as it executes a significant national scale-up of its pharmacy-based point-of-care platform, HealthTab(TM). Interested parties sh...
VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is excited to offer a live discussion on the Company’s current activities and forward outlook as it executes a significant nationa...
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) participated in the recent Health Care Innovation event, sponsored by Globe and Mail. The event featured leaders from an array of sectors in the space, including Avricore Health CEO Hector Bremner. The premier event included health sector l...
VANCOUVER, British Columbia , Sept. 19, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) was honoured to join the Globe and Mail’s recent Health Care Innovation event, featuring leaders from various corners of the sect...
Avricore Health press release ( OTC:AVCRF ): Q2 GAAP EPS of $0.00. Revenue of $176.17K (+3466.2% Y/Y). For further details see: Avricore Health reports Q2 reults
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is reporting on its second-quarter 2022 financial results and sharing a corporate update. According to the announcement, key developments for the company have included a significant increase of Shoppers Drug Mart(R) pharmacies offering AVCR...
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is pleased to provide this corporate update on the Company’s Q2 results. “We have now begun a new era for Healthtab...
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) announced that its board of directors has approved the granting of stock options exercisable for a total of 2,725,000 common shares to its directors, officers and consultants at an exercise price of CA$0.15 per common share. According to the upd...
VANCOUVER, British Columbia, Aug. 10, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is pleased to announce that the Company’s board of directors has approved the granting of stock options (the “Options”...
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that it is significantly expanding the number of Shoppers Drug Mart pharmacies offering its HealthTab(TM) point-of-care testing platform under a renewed master service agreement (“MSA”) to up to 450 locations nation...
News, Short Squeeze, Breakout and More Instantly...
Avricore Health Inc. Company Name:
AVCRF Stock Symbol:
OTCMKTS Market:
Avricore Health Inc. Website:
VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) reports on results for the first three months of 2024, the first period of net profitability for the Company. The Company realiz...
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross pr...
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTab™ with Rexall Pharmacy Group ULC (“Rexall...